Combination Treatment with Antigen-Specific Dual-Sized Microparticle System Plus Anti-CD3 Immunotherapy Fails to Synergize to Improve Late-Stage Type 1 Diabetes Prevention in Nonobese Diabetic Mice-Reference-Cited by-同舟云学术

Combination Treatment with Antigen-Specific Dual-Sized Microparticle System Plus Anti-CD3 Immunotherapy Fails to Synergize to Improve Late-Stage Type 1 Diabetes Prevention in Nonobese Diabetic Mice

Published:2020-09-01 Issue:10 Volume:6 Page:5941-5958
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

Stewart J. M.¹,Posgai A. L.²,Leon J. J.¹,Haller M. J.³,Keselowsky B. G.¹²^ORCID

Affiliation:

1. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida 32611, United States

2. Department of Pathology, Immunology and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida 32611, United States

3. Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32611, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Allergy and Infectious Diseases

University of Florida

McJunkin Family Charitable Foundation, Inc

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.0c01075

Reference51 articles.

1. Type 1 diabetes

2. Formation of a Human β-Cell Population within Pancreatic Islets Is Set Early in Life

3. Type 1 diabetes immunotherapy using polyclonal regulatory T cells

4. Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

5. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery Route Considerations for Designing Antigen‐Specific Biomaterial Strategies to Combat Autoimmunity;Advanced NanoBiomed Research;2023-01-29

2. Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps;Advanced Science;2023-01-13

3. Leverage biomaterials to modulate immunity for type 1 diabetes;Frontiers in Immunology;2022-11-02

4. Biomaterials‐based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents;Journal of Biomedical Materials Research Part A;2022-09-09

5. Local delivery strategies to restore immune homeostasis in the context of inflammation;Advanced Drug Delivery Reviews;2021-11